Targeting the Molecular and Immunologic Features of Leiomyosarcoma
Brandon Cope(Keesler Medical Center), Elise F. Nassif(The University of Texas MD Anderson Cancer Center)
Cited by 26
Related Papers
ETCTN 10563: A phase I study of peposertib and liposomal doxorubicin for advanced or metastatic leiomyosarcoma and other sarcomas.
|Journal of Clinical Oncology|2025|1